Global CRISPR/Cas9 Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook - 2019-2027

Date: May 14 2020
|
AllTheResearch (Featured Publisher)
|
Number of Pages: 135
|
Alternate Text Alternate Text Alternate Text Alternate Text
Category: Medical Care

The global crispr/cas9 market was valued at US$ XX Mn in 2019 and is expected to reach US$ XX Mn by the end of the forecast period, growing at a CAGR of XX% during the period from 2020 to 2027.

The research report segments the market from a relevancy perspective into the below segments and sub-segments with quantitative analysis done from 2019 to 2027 considering 2019 as the base year for the research. Compounded Annual Growth Rate (CAGR) for each respective segment and sub-segment is calculated for the forecast period from 2020 to 2027 to provide a reference for growth potential.

Market Segments and Sub-segments Covered in the Report:

Based on Product Type crispr/cas9 market is segmented into:
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Based on Application crispr/cas9 market is segmented into:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes

Based on Geography crispr/cas9 market is segmented into:
North America (U.S. and Canada)
Europe (U.K., Germany, France, Spain, Italy and Rest of Europe)
Asia Pacific (China, Japan, India, Indonesia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)

Key Market Players Analysed and Profiled in the Study Include:
Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego

This report covers an in-depth analysis of the crispr/cas9 market including statistical and qualitative data points with emphasis on the market dynamics including the drivers, opportunities & restraints.

There is a coverage of market dynamics at country level in the respective regional segments. The report comprises competitive analysis with focus on key players and participants of crispr/cas9 market covering in-depth data related to competitive landscape, positioning, company profiles, key strategies adopted and product-profiling with focus on market growth and potential.

Key Questions answered in the Report:

• What is the size of the overall crispr/cas9 market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the crispr/cas9 market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Market?
• What is the crispr/cas9 market size at the regional and country level?
• Who are the key market players and their key competitors?
• Market value- chain and key trends impacting every node with reference to companies
• What are the strategies for growth adopted by the key players in crispr/cas9 market?
• How does a particular company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization?
• How financially strong are the key players in crispr/cas9 market (revenue and profit margin, market capitalization, expenditure analysis, investment analysis)?
• What are the recent trends in crispr/cas9 market? (M&A, partnerships, new product developments, expansions)

Years Considered During the Study:

Historical Year: 2017 and 2018
Base Year: 2019
Forecast Period: 2020 to 2027

Chapter 1 Preface
   1.1 Report Description
          1.1.1 Purpose of the Report
          1.1.2 Target Audience
          1.1.3 USP and Key Offerings
   1.2 Research Scope
   1.3 Research Methodology
          1.3.1 Secondary Research
          1.3.2 Primary Research
          1.3.3 Expert Panel Review
          1.3.4 Approach Adopted
                1.3.4.1 Top-Down Approach
                1.3.4.2 Bottom-Up Approach
          1.3.5 Assumptions
   1.4 Market Segmentation Scope
Chapter 2 Executive Summary
   2.1 Market Summary
          2.1.1 Global CRISPR/Cas9 Market, 2017-2027, (US$ Mn)
   2.2 Market Snapshot: Global CRISPR/Cas9 Market
          2.2.1 Market Dynamics (DRO)
   2.3 Global CRISPR/Cas9 Market, by Segment, 2019
          2.3.1 Global CRISPR/Cas9 Market, by Region, 2019 (US$ Mn)
          2.3.2 Global CRISPR/Cas9 Market, by Product Type, 2019 (US$ Mn)
          2.3.3 Global CRISPR/Cas9 Market, by Application, 2019 (US$ Mn)
   2.4 Premium Insights
          2.4.1 Market In Developed Vs. Developing Economies, 2019 vs 2027
          2.4.2 Market Regional Life Cycle Analysis
          2.4.3 Pricing Analysis, by Region
                2.4.3.1 Pricing by Product
                2.4.3.2 Pricing by Applications
                2.4.3.3 Pricing by Geography/Regions
          2.4.4 Technological Integrations
          2.4.5 Supply Chain Analysis and Vendor Landscaping
          2.4.6 Emerging Player Analysis
          2.4.7 Major Investments in Market
          2.4.8 Mega Trend Analysis
          2.4.9 Regulatory Analysis
          2.4.10 Key Factors Influencing Purchasing/Buying Decisions
          2.4.11 Market Pain-Points and Unmet Needs
          2.4.12 Key Stakeholder analysis (patients, physicians, competition and more)
Chapter 3 Market Dynamics
   3.1 Market Overview
   3.2 Market Driver, Restraint and Opportunity Analysis
   3.3 Market Ecosystem Analysis
   3.4 Market Trends Analysis
   3.5 Industry Value Chain Analysis
   3.6 Market Analysis
          3.6.1 SWOT Analysis
          3.6.2 Porter's 5 Forces Analysis
   3.7 Analyst Views
Chapter 4 Global CRISPR/Cas9 Market, by Product Type
   4.1 Market Overview, by Product Type
          4.1.1 Incremental Opportunity, by Product Type, 2019-2027

Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Chapter 5 Global CRISPR/Cas9 Market, by Application
   5.1 Market Overview, by Application
          5.1.1 Incremental Opportunity, by Application, 2019-2027

Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Chapter 6 Global CRISPR/Cas9 Market, by Region
   6.1 Market Overview, by Region
          6.1.1 Global CRISPR/Cas9 Market, by Region, 2017-2027, (US$ Mn)
   6.2 Incremental Opportunity, by Region, 2019
   6.3 North America CRISPR/Cas9 Market
          6.3.1 North America CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
          6.3.2 North America CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
          6.3.3 North America CRISPR/Cas9 Market, by Country, 2017-2027 (US$ Mn)
                6.3.3.1 U.S.
                   6.3.3.1.1 U.S. CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.3.3.1.2 U.S. CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.3.3.2 Canada
                   6.3.3.2.1 Canada CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.3.3.2.2 Canada CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
   6.4 Europe CRISPR/Cas9 Market
          6.4.1 Europe CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
          6.4.2 Europe CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
          6.4.3 Europe CRISPR/Cas9 Market, by Country, 2017-2027 (US$ Mn)
                6.4.3.1 U.K.
                   6.4.3.1.1 U.K. CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.1.2 U.K. CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.2 Germany
                   6.4.3.2.1 Germany CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.2.2 Germany CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.3 France
                   6.4.3.3.1 France CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.3.2 France CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.4 Italy
                   6.4.3.4.1 Italy CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.4.2 Italy CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.5 Spain
                   6.4.3.5.1 Spain CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.5.2 Spain CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.6 Rest of Europe
                   6.4.3.6.1 Rest of Europe CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.6.2 Rest of Europe CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
   6.5 Asia Pacific CRISPR/Cas9 Market
          6.5.1 Asia Pacific CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
          6.5.2 Asia Pacific CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
          6.5.3 Asia Pacific CRISPR/Cas9 Market, by Country, 2017-2027 (US$ Mn)
                6.5.3.1 China
                   6.5.3.1.1 China CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.1.2 China CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.2 India
                   6.5.3.2.1 India CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.2.2 India CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.3 Japan
                   6.5.3.3.1 Japan CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.3.2 Japan CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.4 Indonesia
                   6.5.3.4.1 Indonesia CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.4.2 Indonesia CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.5 Rest of Asia Pacific
                   6.5.3.5.1 Rest of Asia Pacific CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.5.2 Rest of Asia Pacific CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
   6.6 Latin America CRISPR/Cas9 Market
          6.6.1 Latin America CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
          6.6.2 Latin America CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
          6.6.3 Latin America CRISPR/Cas9 Market, by Country, 2017-2027 (US$ Mn)
                6.6.3.1 Brazil
                   6.6.3.1.1 Brazil CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.6.3.1.2 Brazil CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.6.3.2 Mexico
                   6.6.3.2.1 Mexico CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.6.3.2.2 Mexico CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.6.3.3 Rest of Latin America
                   6.6.3.3.1 Rest of Latin America CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.6.3.3.2 Rest of Latin America CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
   6.7 Middle East & Africa CRISPR/Cas9 Market
          6.7.1 Middle East & Africa CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
          6.7.2 Middle East & Africa CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
          6.7.3 Middle East & Africa CRISPR/Cas9 Market, by Region/Country, 2017-2027 (US$ Mn)
                6.7.3.1 GCC
                   6.7.3.1.1 GCC CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.7.3.1.2 GCC CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.7.3.2 South Africa
                   6.7.3.2.1 South Africa CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.7.3.2.2 South Africa CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
                6.7.3.3 Rest of Middle East & Africa
                   6.7.3.3.1 Rest of Middle East & Africa CRISPR/Cas9 Market, by Product Type, 2017-2027 (US$ Mn)
                   6.7.3.3.2 Rest of Middle East & Africa CRISPR/Cas9 Market, by Application, 2017-2027 (US$ Mn)
Chapter 7 Competitive Intelligence
   7.1 Market Players Present in Market Life Cycle
   7.2 Key Player Analysis
   7.3 Market Positioning
   7.4 Market Players Mapping, vis-à-vis Ecosystem
          7.4.1 By Segments
          7.4.2 By Region
   7.5 Strategies Adopted by Key Market Players
   7.6 Recent Developments in the Market
          7.6.1 Organic (New Product Launches, R&D, Financial, Technology)
          7.6.2 Inorganic (Mergers & Acquisitions, Partnership and Alliances, Fund Raise)
Chapter 8 Company Profiles - with focus on Company Fundamentals, Product Portfolio, Financial Analysis, Recent News and Developments, Key Strategic Instances, SWOT Analysis

Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Chapter 9 About Us

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.